Analyst Ratings for Ultragenyx Pharma (RARE)
RARE Rating Summary
RARE Price Target Summary
- Highest: $181.00 (Jefferies)
- Lowest: $91.00 (Canaccord Genuity)
- Average: $142.27
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$142.27 (+51.8%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 64%
Avg. $ Target:
$142.27 (+51.8%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 64%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/4/2021 | Baird | Joel Beatty | New Coverage | Neutral (N/A) |
109.00 (N/A) |
97.70 (93.72) |
-4.07% | Details |
| 5/6/2021 | Citi | Yigal Nochomovitz | Upgrade | Buy (Neutral) |
151.00 (160.00) |
101.85 (93.72) |
-7.98% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
